TAYEBATI, Seyed Khosrow
 Distribuzione geografica
Continente #
NA - Nord America 22.853
AS - Asia 13.180
EU - Europa 13.160
SA - Sud America 1.330
AF - Africa 350
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 41
Totale 50.961
Nazione #
US - Stati Uniti d'America 21.861
CN - Cina 5.129
SG - Singapore 3.295
RU - Federazione Russa 2.916
IT - Italia 2.704
HK - Hong Kong 2.074
PL - Polonia 1.770
BR - Brasile 1.106
FR - Francia 1.070
UA - Ucraina 1.051
DE - Germania 1.043
VN - Vietnam 867
CA - Canada 798
SE - Svezia 776
GB - Regno Unito 600
FI - Finlandia 511
TR - Turchia 440
KR - Corea 424
IE - Irlanda 251
ZA - Sudafrica 231
IN - India 209
BD - Bangladesh 144
MX - Messico 126
NL - Olanda 122
AR - Argentina 74
IQ - Iraq 70
JP - Giappone 68
IR - Iran 63
PK - Pakistan 62
CH - Svizzera 55
CZ - Repubblica Ceca 55
ID - Indonesia 47
EU - Europa 44
ES - Italia 40
AU - Australia 35
EC - Ecuador 34
BE - Belgio 32
MY - Malesia 32
GR - Grecia 31
MA - Marocco 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
CO - Colombia 27
PE - Perù 24
TW - Taiwan 23
LT - Lituania 21
AT - Austria 20
PH - Filippine 20
AE - Emirati Arabi Uniti 19
CL - Cile 19
VE - Venezuela 19
EG - Egitto 18
JM - Giamaica 16
TH - Thailandia 16
RO - Romania 15
IL - Israele 14
NP - Nepal 14
AZ - Azerbaigian 13
DZ - Algeria 13
PY - Paraguay 13
JO - Giordania 12
TN - Tunisia 12
AL - Albania 10
EE - Estonia 10
KZ - Kazakistan 10
UY - Uruguay 10
CR - Costa Rica 9
DK - Danimarca 9
HU - Ungheria 8
PA - Panama 8
TT - Trinidad e Tobago 8
GH - Ghana 7
KE - Kenya 7
KG - Kirghizistan 7
NG - Nigeria 7
NO - Norvegia 7
RS - Serbia 7
HN - Honduras 6
LB - Libano 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
OM - Oman 5
BO - Bolivia 4
GA - Gabon 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
CM - Camerun 3
CY - Cipro 3
ET - Etiopia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
Totale 50.915
Città #
Jacksonville 2.195
Hong Kong 2.047
Ashburn 1.801
Warsaw 1.572
Singapore 1.489
Fairfield 1.322
San Jose 1.321
Chandler 1.230
Woodbridge 1.163
Boardman 1.014
Houston 913
Wilmington 785
Beijing 667
Ann Arbor 626
Seattle 595
Nanjing 585
Toronto 566
The Dalles 496
Council Bluffs 449
Cambridge 448
Los Angeles 373
Seoul 372
Tongling 348
Istanbul 343
Lawrence 336
Princeton 336
San Mateo 331
Columbus 307
Shanghai 307
Lauterbourg 301
Camerino 298
Helsinki 290
New York 271
Ogden 271
Ho Chi Minh City 269
Dearborn 240
Dublin 235
St Louis 233
Nanchang 224
Dallas 223
Johannesburg 205
Centro 188
Guangzhou 182
Buffalo 166
Dong Ket 160
Moscow 160
Trieste 156
Hanoi 150
Zhengzhou 147
Kraków 146
Jiaxing 134
Milan 133
Santa Clara 120
Shenyang 119
Kunming 116
Lachine 112
London 110
Orem 108
Düsseldorf 107
São Paulo 105
Chicago 101
Munich 101
Rome 101
Tianjin 95
Hebei 90
Redondo Beach 89
Philadelphia 81
Bremen 76
Wuhan 76
Frankfurt am Main 71
Redwood City 69
Changsha 66
Hangzhou 65
Chennai 60
Tokyo 59
San Diego 56
Denver 55
Jinan 54
Montreal 54
Vinnytsia 54
Atlanta 53
Rio de Janeiro 52
Mexico City 50
Basingstoke 45
Falls Church 45
Kocaeli 44
Hefei 43
Norwalk 41
Shenzhen 41
Brooklyn 40
Manchester 40
Phoenix 38
Stockholm 38
Lanzhou 37
Detroit 35
Mumbai 35
Orange 34
San Francisco 34
Verona 34
Venezia 33
Totale 32.301
Nome #
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children. 1.199
Effetti neuroprotettivi del Nerve Growth Factor somministrato come collirio in bambini e giovani adulti con deficits visivi indotti da gliomi delle vie ottiche 756
A multidisciplinary approach to study the brain injury in Diet-Induced (DIO) rats 506
Metabolic effects of tart Cherries Supplementation in an animal model of obesity 469
Anatomia del Gray, I Fondamenti 402
Neurological Disorder, Stroke: Relevance of Preclinical Studies 384
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain 368
Effects of Tart Cherry supplementation in Diet-Induced Obesity (DIO) rats. 359
Obesity-related nervous system injury: preliminary evidences in diet induced obesity (DIO) rats. 349
Telerehabilitation: Review of the State-of-the-Art and Areas of Application 342
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 339
Obesity affects central nervous system: a multidisciplinary study in Diet-Induced Obesity (DIO) rats 317
EXPRESSION OF SINAPTO-VESICULAR PROTEINS IN BRAIN AREAS OF AN ANIMAL MODEL OF METABOLIC SYNDROME 315
Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study 315
Frontiers in Molecular Biosciences 312
Process mining case study approach: Extraction of unconventional event logs to improve performance in Hospital Information Systems (HIS) 311
Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes. 303
THE OBESE ZUCKER RATS: AN IN VIVO MODEL FOR STUDYING THE LIVER CARBONIC ANHYDRASE CAVII BIOLOGICAL ROLE 288
Brain alterations in high fat diet induced obesity: Effects of tart cherry seeds and juice 266
Brain Activity of Thioctic Acid Enantiomers: In Vitro and in Vivo Studies in an Animal Model of Cerebrovascular Injury 261
Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. 251
Comparative analysis of the medicinal compounds of the ship's "medicine chests" in European Union maritime countries. Need for improvement and harmonization 250
ACETYLCHOLINE PRECURSORS ATTENUATE NEUROINFLAMMATION IN LPS-STIMULATED BV2 CELLS 249
Adrenergic receptor subtypes in human peripheral blood lymphocytes. 249
Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. 249
Guida alla Farmacia di Bordo 248
Editorial Board of Neurosurgery Cases and Reviews 244
Comparative machine-learning approach: A follow-up study on type 2 diabetes predictions by cross-validation methods 242
OBESITY-RELATED CEREBROVASCULAR INJURY IN OBESE ZUCKER RATS 241
Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. 241
Report on market analysis and preventions need to provide medications for rural patients of Italy using ICT technologies 241
Effects of acetylcholine precursors on inflammation in rat brain 240
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 237
PROTECTIVE ACITIVITY OF THE CHOLINE CONTAINING PHOSPHOLIPID CHOLINE ALPHOSCERATE, ON CEREBROVASCULAR TREE OF SPONTANEOUSLY HYPERTENSIVE RATS 234
A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. 228
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate. 227
Discovery of Highly Selective Imidazoline Receptor Ligands 224
Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity 224
Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor 221
(Neuro)transmitter systems in circulating immune cells: a target of immunopharmacological interventions? 218
THE PHARMACIST KNOWLEDGE AND COMPUTER SKILLS TOWARDS E-HEALTH. RESULTS OF A SURVEY AMONG ITALIAN COMMUNITY PHARMACISTS 218
ACTIVITY OF THIOCTIC ACID ENANTIOMERS ON SPINAL CORD CHANGES CONSEQUENT TO PERIPHERAL NERVE INJURY 216
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes 215
Brain cholinergic dysfunction in obese Zucker LEPR(fa/fa) rats 213
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook. 210
Age-related changes in the brain of obese Zucker rat: Morphological and immunochemical analysis. 210
Ein neues klinisches Syndrom bedingt durch eine Defizienz des muskarinergen M3-Rezeptors: Trias aus bilateraler Mydriasis, Blasenentleerungsstörung und schlankem Habitus 208
Obesity-related blood brain barrier changes in obese Zucker rats 207
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells 206
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 206
Policies and challenges on the distribution of specialists and subspecialists in rural areas of Iran 206
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats 200
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission 199
Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats. 198
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 197
Occupancy by oral administration of nicardipine of L-type calcium channels in rat brain 196
Dementias and cognitive disorders: New insights and approaches 196
ACTIVITY OF CHOLINE ALPHOSCERATE ON CEREBROVASCULAR MORPHOLOGY AND INFLAMMATORY MARKERS IN SPONTANEOUSLY HYPERTENSIVE RATS 194
Heart morphology in Zucker-obese rats 194
Cardiovascular changes related to metabolic syndrome: Evidence in obese zucker rats 194
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries 192
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 191
Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds 189
Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. 188
ALLA SCOPERTA DEL RUOLO DELL’INVECCHIAMENTO E DEL SESSO NEI PROCESSI DEGENERATIVI FISIOLOGICI E PATOLOGICI DEI NERVI PERIFERICI. 188
Muscarinic Thioligands with Cyclopentane Nucleus 187
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. 185
Obesity and Metabolic Syndrome Affects the Cholinergic Transmission and Cognitive Functions 185
Dopamine and vascular dynamics control: present status and future perspectives. 184
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 183
NEUROPLASTICITY OF ENTERIC NERVOUS SYSTEM IN ANIMAL MODEL OF OBESITY 182
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. 181
TREATMENT WITH A CHOLINERGIC PRECURSOR IN AN ANIMAL MODEL OF CEREBROVASCULAR DISEASE: INSIGHTS INTO MECHANISMS OF NEUROPROTECTIVE ACTIVITY 181
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 180
Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study 180
Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands 180
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 179
Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures 177
Animal models of cognitive dysfunction. 177
Potential dopamine-1 receptor stimulation in hypertension management. 177
Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior. 177
Influence of dermal exposure to the pyrethroid insecticide deltamethrin on rat brain microanatomy and cholinergic/dopaminergic neurochemistry. 177
Evaluation of an Agonist Index: Affinity Ratio for Compounds Active on Muscarinic Cholinergic M2 Receptors 175
Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. 175
Member of SCIENTIFIC ADVISORY BOARD of 9th International Congress on Vascular Dementia 175
Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study 174
Dopamine receptors in human platelets. 173
BRAIN MORPHOLOGICAL ANALYSIS OF OBESE ZUCKER RAT: MODEL OF METABOLIC SYNDROME. 173
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 173
Muscarinic cholinergic receptors subtypes in rat cerebellar cortex: light microscope autoradiography of age-related changes 172
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. 172
Muscarinic cholinergic receptor subtypes in cerebral cortex of Fisher 344 rats: a light microscope autoradiography study of age-related changes. 171
Does obesity affect the mucin secretion of the rat intestinal mucosa? 171
ALPHA1-ADRENERGIC RECEPTOR SUBTYPES HUMAN PERIPHERAL BLOOD LYMPHOCYTES 170
Choline-containing phospholipids: relevance to brain functional pathways. 170
Modulation Of Monoaminergic Transporters By Choline-Containing Phospholipids In Rat Brain. 170
Batten disease through different in vivo and in vitro models: A review 170
The dopaminergic system in hypertension 169
Identification of adenosine A1 and A3 receptor subtypes in rat pial and intracerebral arteries. 169
Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study 168
Totale 24.112
Categoria #
all - tutte 217.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 0 0 0 0 0 0 626
2021/20222.957 110 784 86 149 257 126 76 216 295 240 222 396
2022/20233.537 456 115 113 418 399 505 55 245 678 226 222 105
2023/20242.984 472 157 196 80 158 234 127 137 390 127 104 802
2024/202510.367 490 292 1.205 789 263 482 930 2.406 709 759 475 1.567
2025/202614.472 742 1.892 995 1.836 1.312 992 2.387 1.230 608 1.045 1.069 364
Totale 51.839